ATHA - Athira Pharma, Inc.
NASDAQ
->
Healthcare
->
Biotechnology
Bothell,
United States
Type: Equity
ATHA price evolution
ATHA
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $82.2 | $78.45 | $91.22 | |
| Short term investments | $17.94 | $44.27 | $56.84 | |
| Net receivables | $1.63 | $1.63 | $1.63 | $1.63 |
| Inventory | ||||
| Total current assets | $82 | $106.7 | $128.64 | $154.73 |
| Long term investments | $0.63 | |||
| Property, plant & equipment | $3.56 | $3.86 | $4.14 | $4.44 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $4.55 | $4.82 | $5.52 | |
| Total investments | $18.57 | $44.27 | $56.84 | |
| Total assets | $86.25 | $111.25 | $133.46 | $160.25 |
| Current liabilities | ||||
| Accounts payable | $0.39 | $0.47 | $0.68 | $0.13 |
| Deferred revenue | ||||
| Short long term debt | $0.39 | $0.38 | $0.37 | |
| Total current liabilities | $27.75 | $26.9 | $25.6 | $28.84 |
| Long term debt | $1.02 | $1.12 | $1.22 | |
| Total noncurrent liabilities | $1.02 | $1.12 | $1.22 | |
| Total debt | $1.41 | $1.5 | $1.58 | |
| Total liabilities | $28.66 | $27.92 | $26.72 | $30.06 |
| Shareholders' equity | ||||
| Retained earnings | -$391.14 | -$362.4 | -$335.54 | -$309.21 |
| Other shareholder equity | $0 | -$0.04 | -$0.14 | -$0.35 |
| Total shareholder equity | $83.33 | $106.74 | $130.19 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $91.22 | $96.39 | $110.54 | $60.63 |
| Short term investments | $56.84 | $104.38 | $143.22 | $124.06 |
| Net receivables | $1.63 | $1.23 | $2.34 | $1.3 |
| Inventory | ||||
| Total current assets | $154.73 | $207.53 | $260.8 | $192.34 |
| Long term investments | $44.83 | $65.94 | $83.51 | |
| Property, plant & equipment | $4.44 | $5.32 | $5.22 | $3.58 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $5.52 | $50.62 | $71.21 | $87.23 |
| Total investments | $56.84 | $149.21 | $209.16 | $207.57 |
| Total assets | $160.25 | $258.15 | $332.01 | $279.56 |
| Current liabilities | ||||
| Accounts payable | $0.13 | $2.5 | $0.57 | $1.16 |
| Deferred revenue | ||||
| Short long term debt | $0.37 | $0.33 | $0.29 | $0.12 |
| Total current liabilities | $28.84 | $21.43 | $9.29 | $4.41 |
| Long term debt | $1.22 | $1.58 | $1.63 | $0.88 |
| Total noncurrent liabilities | $1.22 | $1.58 | $1.63 | $0.88 |
| Total debt | $1.58 | $1.91 | $1.92 | $1 |
| Total liabilities | $30.06 | $23.02 | $10.92 | $5.28 |
| Shareholders' equity | ||||
| Retained earnings | -$309.21 | -$191.53 | -$95.89 | -$41.04 |
| Other shareholder equity | -$0.35 | -$1.96 | -$0.39 | $0.03 |
| Total shareholder equity | $130.19 | $235.14 | $321.08 | $274.28 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $22.15 | $21.24 | $23.68 | |
| Selling, general & administrative | $5.87 | $6.45 | $6.96 | |
| Total operating expenses | $28.03 | $27.69 | $29.01 | |
| Operating income | -$28.03 | -$27.69 | -$29.01 | |
| Income from continuing operations | ||||
| EBIT | -$26.86 | -$26.34 | -$27.29 | |
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | -$26.86 | -$26.34 | -$27.29 | |
| Income (for common shares) | -$26.86 | -$26.34 | -$27.29 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $93.79 | $61.46 | $42.79 | $13.29 |
| Selling, general & administrative | $33.3 | $32.55 | $21.23 | $6.71 |
| Total operating expenses | $125.47 | $104.02 | $64.02 | $20 |
| Operating income | -$125.47 | -$104.02 | -$64.02 | -$20 |
| Income from continuing operations | ||||
| EBIT | -$117.67 | -$95.64 | -$54.85 | -$19.95 |
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | -$117.67 | -$95.64 | -$54.85 | -$19.95 |
| Income (for common shares) | -$117.67 | -$95.64 | -$54.85 | -$19.95 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$26.86 | -$26.34 | -$27.29 | |
| Operating activities | ||||
| Depreciation | $0.3 | $0.3 | $0.3 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $3.21 | $2.68 | $2.23 | |
| Total cash flows from operations | -$22.33 | -$25.8 | -$26.29 | |
| Investing activities | ||||
| Capital expenditures | -$0.03 | -$0.01 | ||
| Investments | $26.59 | $13.05 | $6.39 | |
| Total cash flows from investing | $57.64 | $26.56 | $13.04 | $6.39 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.15 | $0.15 | ||
| Net borrowings | ||||
| Total cash flows from financing | $0.16 | $0.15 | $0.15 | |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$13.35 | $4.38 | -$12.76 | -$19.75 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$117.67 | -$95.64 | -$54.85 | -$19.95 |
| Operating activities | ||||
| Depreciation | $1.18 | $1.05 | $0.48 | |
| Business acquisitions & disposals | $0.04 | |||
| Stock-based compensation | $10.62 | $10.61 | $4.62 | $0.63 |
| Total cash flows from operations | -$100.75 | -$72.47 | -$43.1 | -$24.11 |
| Investing activities | ||||
| Capital expenditures | -$0.3 | -$1.14 | -$1.57 | -$2.32 |
| Investments | $95.39 | $58.8 | -$2.51 | -$207.78 |
| Total cash flows from investing | $95.09 | $57.66 | -$4.08 | -$210.07 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.49 | $0.65 | $97.09 | $209.16 |
| Net borrowings | $1.66 | |||
| Total cash flows from financing | $0.49 | $0.65 | $97.09 | $292.75 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$5.17 | -$14.15 | $49.91 | $58.57 |
News
Fundamentals
| Market cap | $160.67M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 38.67M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.23 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.95 |
| Quick ratio | N/A |